Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17: 545–580
Chen J, Cheng Z, Miao Y, Jurisson SS, Quinn TP (2002) Alpha-melanocyte-stimulating hormone peptide analogs labeled with technetium-99m and indium-111 for malignant melanoma targeting. Cancer 94: 1196–1201
Chaudhuri TR, Rogers BE, Buchsbaum DJ, Mountz JM, Zinn KR (2001) A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts. Gynecol Oncol 83: 432–438
Barrio JR, Huang SC, Phelps ME (1997) Biological imaging and the molecular basis of dopaminergic diseases. Biochem Pharmacol 54: 341–348
MacLaren DC, Gambhir SS, Satyamurthy N, Barrio JR, Sharfstein S, Toyokuni T, Wu L, Berk AJ, Cherry SR, Phelps ME et al (1999) Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 6: 785–791
Iyer M, Barrio JR, Namavari M, Bauer E, Satyamurthy N, Nguyen K, Toyokuni T, Phelps ME, Herschman HR, Gambhir SS (2001) 8-[18F]Fluoropenciclovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med 42: 96–105
Tjuvajev JG, Doubrovin M, Akhurst T, Cai S, Balatoni J, Alauddin MM, Finn R, Bornmann W, Thaler H, Conti PS et al (2002) Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med 43: 1072–1083
Contag CH, Bachmann MH (2002) Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4: 235–260
Groot-Wassink T, Aboagye EO, Glaser M, Lemoine NR, Vassaux G (2002) Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum Gene Ther 13: 1723–1735
Groot-Wassink T, Aboagye EO, Wang Y, Lemoine NR, Reader AJ, Vassaux G (2004) Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. Mol Ther 9: 436–442
Shao Y, Cherry SR, Farahani K, Meadors K, Siegel S, Silverman RW, Marsden PK (1997) Simultaneous PET and MR imaging. Phys Med Biol 42: 1965–1970
Kastis GK, Barber HB, Barrett HH, Gifford HC, Pang IW, Patton DD, Sain JD, Stevenson G, Wilson DW (1998) High resolution SPECT imager for three-dimensional imaging of small animals. Journal of Nuclear Medicine 39: 9P
Sharma V, Luker GD, Piwnica-Worms D (2002) Molecular imaging of gene expression and protein function in vivo with PET and SPECT. J Magn Reson Imaging 16: 336–351
Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219:316–33.
Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2: 683–693
Cherry SR, Gambhir SS (2001) Use of positron emission tomography in animal research. Ilar J 42: 219–232
Blockmans D (2003) The use of (18F)fluoro-deoxyglucose positron emission tomography in the assessment of large vessel vasculitis. Clin Exp Rheumatol 21: S15–S22
Meller J, Becker W (2001) [Nuclear medicine diagnosis of patients with fever of unknown origin (FUO)]. Nuklearmedizin 40: 59–70
Chatziioannou A, Tai YC, Doshi N, Cherry SR (2001) Detector development for microPET II: a 1 microl resolution PET scanner for small animal imaging. Phys Med Biol 46: 2899–2910
Chatziioannou AF (2002) Molecular imaging of small animals with dedicated PET tomographs. Eur J Nucl Med Mol Imaging 29: 98–114
Strijckmans K (2001) The isochronous cyclotron: principles and recent developments. Comput Med Imaging Graph 25: 69–78
Phelps ME, Hoffman EJ, Mullani NA, Ter-Pogossian MM (1975) Application of annihilation coincidence detection to transaxial reconstruction tomography. Journal of Nuclear Medicine 16: 210–224
Yu Y, Annala AJ, Barrio JR, Toyokuni T, Satyamurthy N, Namavari M, Cherry SR, Phelps ME, Herschman HR, Gambhir SS (2000) Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med 6: 933–937
Liang Q, Satyamurthy N, Barrio JR, Toyokuni T, Phelps MP, Gambhir SS, Herschman HR (2001) Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther 8: 1490–1498
Herschman HR, MacLaren DC, Iyer M, Namavari M, Bobinski K, Green LA, Wu L, Berk AJ, Toyokuni T, Barrio JR et al (2000) Seeing is believing: non-invasive, quantitative and repetitive imaging of reporter gene expression in living animals, using positron emission tomography. J Neurosci Res 59: 699–705
Gambhir SS, Herschman HR, Cherry SR, Barrio JR, Satyamurthy N, Toyokuni T, Phelps ME, Larson SM, Balatoni J, Finn R et al (2000) Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2: 118–138
Foster KA, Roberts MS (2000) Experimental methods for studying drug uptake in the head and brain. Curr Drug Metab 1: 333–356
Pauwels EK, Ribeiro MJ, Stoot JH, McCready VR, Bourguignon M, Maziere B (1998) FDG accumulation and tumor biology. Nucl Med Biol 25: 317–322
Romer W, Hanauske AR, Ziegler S, Thodtmann R, Weber W, Fuchs C, Enne W, Herz M, Nerl C, Garbrecht M et al (1998) Positron emission tomography in non-Hodgkin’s lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood 91: 4464–4471
Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R (1993) Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol 11: 2101–2111
Findlay M, Young H, Cunningham D, Iveson A, Cronin B, Hickish T, Pratt B, Husband J, Flower M, Ott R (1996) Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol 14: 700–708
Stroobants S, Goeminne J, Seegers M, Dimitrijevic S, Dupont P, Nuyts J, Martens M, van den Borne B, Cole P, Sciot R et al (2003) 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer 39: 2012–2020
Jager PL, Gietema JA, van der Graaf WT (2004) Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET. Nucl Med Commun 25: 433–438
Conti PS, Alauddin MM, Fissekis JR, Schmall B, Watanabe KA (1995) Synthesis of 2′-fluoro-5-[11C]-methyl-1-beta-D-arabinofuranosyluracil ([11C]-FMAU): a potential nucleoside analog for in vivo study of cellular proliferation with PET. Nucl Med Biol 22: 783–789
Shields AF (2003) PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls. J Nucl Med 44: 1432–1434
Mankoff DA, Shields AF, Krohn KA (2005) PET imaging of cellular proliferation. Radiol Clin North Am 43: 153–167
Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, Obradovich JE, Muzik O, Mangner TJ (1998) Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 4: 1334–1336
Grierson JR, Schwartz JL, Muzi M, Jordan R, Krohn KA (2004) Metabolism of 3′-deoxy-3′-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography. Nucl Med Biol 31: 829–837
Waldherr C, Mellinghoff IK, Tran C, Halpern BS, Rozengurt N, Safaei A, Weber WA, Stout D, Satyamurthy N, Barrio J et al (2005) Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3′-deoxy-3′-18F-fluorothymidine PET. J Nucl Med 46: 114–120
Barthel H, Cleij MC, Collingridge DR, Hutchinson OC, Osman S, He Q, Luthra SK, Brady F, Price PM, Aboagye EO (2003) 3′-deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res 63: 3791–3798
Volkow ND, Fowler JS, Wang GJ, Dewey SL, Schlyer D, MacGregor R, Logan J, Alexoff D, Shea C, Hitzemann R et al (1993) Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. J Nucl Med 34: 609–613
Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, MacGregor R et al (1994) Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 16: 255–262
Piccini P, Brooks DJ, Bjorklund A, Gunn RN, Grasby PM, Rimoldi O, Brundin P, Hagell P, Rehncrona S, Widner H et al (1999) Dopamine release from nigral transplants visualized in vivo in a Parkinson’s patient. Nat Neurosci 2: 1137–1140
Piccini P, Pavese N, Brooks DJ (2003) Endogenous dopamine release after pharmacological challenges in Parkinson’s disease. Ann Neurol 53: 647–653
Salazar DE, Fischman AJ (1999) Central nervous system pharmacokinetics of psychiatric drugs. J Clin Pharmacol Suppl: 10S–12S
Yanai M, Hatazawa J, Ojima F, Sasaki H, Itoh M, Ido T (1998) Deposition and clearance of inhaled 18FDG powder in patients with chronic obstructive pulmonary disease. Eur Respir J 11: 1342–1348
Haradahira T, Zhang M, Maeda J, Okauchi T, Kawabe K, Kida T, Suzuki K, Suhara T (2000) A strategy for increasing the brain uptake of a radioligand in animals: use of a drug that inhibits plasma protein binding. Nucl Med Biol 27: 357–360
Berridge MS, Heald DL (1999) In vivo characterization of inhaled pharmaceuticals using quantitative positron emission tomography. J Clin Pharmacol Suppl: 25S–29S
Farde L, Wiesel FA, Halldin C, Sedvall G (1988) Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45: 71–76
Waarde A (2000) Measuring receptor occupancy with PET. Curr Pharm Des 6: 1593–1610
Bench CJ, Lammertsma AA, Grasby PM, Dolan RJ, Warrington SJ, Boyce M, Gunn KP, Brannick LY, Frackowiak RS (1996) The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomography. Psychopharmacology (Berl) 124: 141–147
Nyberg S, Farde L, Eriksson L, Halldin C, Eriksson B (1993) 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone. Psychopharmacology (Berl) 110: 265–272
Hode Y, Reimold M, Demazieres A, Reischl G, Bayle F, Nuss P, Hameg A, Dib M, Macher JP (2005) A positron emission tomography (PET) study of cerebral dopamine D(2) and serotonine 5-HT(2A) receptor occupancy in patients treated with cyamemazine (Tercian). Psychopharmacology (Berl) Mar 15; [Epub ahead of print]
Farde L (1996) The advantage of using positron emission tomography in drug research. Trends Neurosci 19: 211–214
Wu JC, Chen IY, Wang Y, Tseng JR, Chhabra A, Salek M, Min JJ, Fishbein MC, Crystal R, Gambhir SS (2004) Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. Circulation 110: 685–691
Shah K, Tang Y, Breakefield X, Weissleder R (2003) Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo. Oncogene 22: 6865–6872
Wu JC, Chen IY, Sundaresan G, Min JJ, De A, Qiao JH, Fishbein MC, Gambhir SS (2003) Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 108: 1302–1305
Yaghoubi SS, Barrio JR, Namavari M, Satyamurthy N, Phelps ME, Herschman HR, Gambhir SS (2005) Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography. Cancer Gene Ther 12: 329–339
Arner ES, Eriksson S (1995) Mammalian deoxyribonucleoside kinases. Pharmacology and Therapeutics 67: 155–186
De Clercq E (1993) Antivirals for the treatment of herpesvirus infections. J Antimicrob Chemother 32: 121–132
Gambhir SS, Bauer E, Black ME, Liang Q, Kokoris MS, Barrio JR, Iyer M, Namavari M, Phelps ME, Herschman HR (2000) A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci USA 97: 2785–2790
Kang K, Min J, Chen X, Gambhir SS (2005) Comparison of [14C]FMAU, [3H]FEAU, [14C]FIAU, and [3H]PCV accumulation in cells expressing wild type or mutant Herpes Simplex Virus type 1 thymidine kinase reporter genes (A). Mol Imaging Biol 7: 138
Tjuvajev JG, Finn R, Watanabe K, Joshi R, Oku T, Kennedy J, Beattie B, Koutcher J, Larson S, Blasberg RG (1996) Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res 56: 4087–4095
Yaghoubi S, Barrio JR, Dahlbom M, Iyer M, Namavari M, Satyamurthy N, Goldman R, Herschman HR, Phelps ME, Gambhir SS (2001) Human pharmacokinetic and dosimetry studies of [(18)F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J Nucl Med 42: 1225–1234
Alauddin MM, Conti PS (1998) Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol 25: 175–180
Alauddin MM, Conti PS, Mazza SM, Hamzeh FM, Lever JR (1996) 9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): a potential imaging agent of viral infection and gene therapy using PET. Nucl Med Biol 23: 787–792
Namavari M, Barrio JR, Toyokuni T, Gambhir SS, Cherry SR, Herschman HR, Phelps ME, Satyamurthy N (2000) Synthesis of 8-[(18)F]fluoroguanine derivatives: in vivo probes for imaging gene expression with positron emission tomography. Nucl Med Biol 27: 157–162
Penuelas I, Mazzolini G, Boan JF, Sangro B, Mart-Climent J, Ruiz M, Satyamurthy N, Qian C, Barrio J, Phelps ME et al (2005) Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology 128: 1787–1795
Jacobs A, Voges J, Reszka R, Lercher M, Gossmann A, Kracht L, Kaestle C, Wagner R, Wienhard K, Heiss WD (2001) Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358: 727–729
Riedel C, Dohan O, De la Vieja A, Ginter CS, Carrasco N (2001) Journey of the iodide transporter NIS: from its molecular identification to its clinical role in cancer. Trends Biochem Sci 26: 490–496
Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N (2003) The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24: 48–77
Eichler O, Hess H, Linder F, Schmeiser K (1951) [Radioiodine therapy of thyroid carcinoma.]. Langenbecks Arch Klin Chir Ver Dtsch Z Chir 269: 19–36
Horst W (1951) [Diagnostic use of radioiodine 131.]. Strahlentherapie 85: 183–186
Klain M, Ricard M, Leboulleux S, Baudin E, Schlumberger M (2002) Radioiodine therapy for papillary and follicular thyroid carcinoma. Eur J Nucl Med Mol Imaging 29,Suppl 2: S479–S485
Manders JM, Corstens FH (2002) Radioiodine therapy of euthyroid multinodular goitres. Eur J Nucl Med Mol Imaging 29,Suppl 2: S466–S470
Reiners C, Schneider P (2002) Radioiodine therapy of thyroid autonomy. Eur J Nucl Med Mol Imaging 29,Suppl 2: S471–S478
Mandell RB, Mandell LZ, Link CJ Jr (1999) Radioisotope concentrator Gene Therapy using the sodium/iodide symporter gene. Cancer Res 59: 661–668
Spitzweg C, Dietz AB, O’Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC (2001) In vivo sodium iodide symporter Gene Therapy of prostate cancer. Gene Ther 8: 1524–1531
Spitzweg C, O’Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC (2000) Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res 60: 6526–6530
Haberkorn U, Henze M, Altmann A, Jiang S, Morr I, Mahmut M, Peschke P, Kubler W, Debus J, Eisenhut M (2001) Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. J Nucl Med 42: 317–325
Rosenthal MS, Cullom J, Hawkins W, Moore SC, Tsui BM, Yester M (1995) Quantitative SPECT imaging: a review and recommendations by the Focus Committee of the Society of Nuclear Medicine Computer and Instrumentation Council. J Nucl Med 36: 1489–1513
Mozley PD, Stubbs JB, Plossl K, Dresel SH, Barraclough ED, Alavi A, Araujo LI, Kung HF (1998) Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters. J Nucl Med 39: 2069–2076
Kuikka JT, Akerman K, Bergstrom KA, Karhu J, Hiltunen J, Haukka J, Heikkinen J, Tiihonen J, Wang S, Neumeyer JL (1995) Iodine-123 labelled N-(2-fluoroethyl)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain. Eur J Nucl Med 22: 682–686
Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342–348
Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC et al (1998) In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 95: 6349–6354
Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Strauss HW (1999) Imaging of apoptosis (programmed cell death) with 99mTc annexin V. J Nucl Med 40: 184–191
Mochizuki T, Kuge Y, Zhao S, Tsukamoto E, Hosokawa M, Strauss HW, Blankenberg FG, Tait JF, Tamaki N (2003) Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V. J Nucl Med 44: 92–97
Belhocine T, Steinmetz N, Green A, Rigo P (2003) In vivo imaging of chemotherapy-induced apoptosis in human cancers. Ann NY Acad Sci 1010: 525–529
Belhocine T, Steinmetz N, Hustinx R, Bartsch P, Jerusalem G, Seidel L, Rigo P, Green A (2002) Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 8: 2766–2774
Mandl SJ, Mari C, Edinger M, Negrin RS, Tait JF, Contag CH, Blankenberg FG (2004) Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. Mol Imaging 3: 1–8
Ross SA, Seibyl JP (2004) Research applications of selected 123I-labeled neuroreceptor SPECT imaging ligands. J Nucl Med Technol 32: 209–214
Bhaumik S, Gambhir S (2002) Optical Imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci USA 99: 377–382
Contag CH, Ross BD (2002) It’s not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imaging 16: 378–387
Levenson R, Mansfield JR, Gossage KW (2005) Hardware and software for optimized multispectral imaging in vivo (A). Mol Imaging Biol 7: 106
Gao X, Cui Y, Levenson RM, Chung LW, Nie S (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22: 969–976
Rice BW, Cable MD, Nelson MB (2001) In vivo imaging of light-emitting probes. J Biomed Opt 6: 432–440
Tromberg BJ, Shah N, Lanning R, Cerussi A, Espinoza J, Pham T, Svaasand L, Butler J (2000) Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2: 26–40
Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Dennery P, Stevenson DK, Benaron DA (1997) Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66: 523–531
Contag PR, Olomu IN, Stevenson DK, Contag CH (1998) Bioluminescent indicators in living mammals. Nat Med 4: 245–247
Baggett B, Roy R, Momen S, Morgan S, Tisi L, Morse D, Gillies RJ (2004) Thermostability of firefly luciferases affects efficiency of detection by in vivo bioluminescence. Mol Imaging 3: 5324–332
Leclerc GM, Boockfor FR, Faught WJ, Frawley LS (2000) Development of a destabilized firefly luciferase enzyme for measurement of gene expression. Biotechniques 29: 590–591, 594-6, 598 passim
Contag CH, Jenkins D, Contag PR, Negrin RS (2000) Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2: 41–52
Bhaumik S, Lewis XZ, Gambhir SS (2004) Optical imaging of Renilla luciferase, synthetic Renilla luciferase, and firefly luciferase reporter gene expression in living mice. J Biomed Opt 9: 578–586
Loening AM, Wu AM, Gambhir SS (2005) Improved mutants of Renilla luciferase for imaging application in living subjects (A). Mol Imaging Biol 7: 143
Loening AM, Paulmurugan R, Wu AM, Gambhir SS (2003) A novel renilla luciferase/epidermal growth factor fusion protein as an optical molecular probe for cancer imaging (A). Mol Imaging 2(3): 132
Park JM, Gambhir SS (2005) Multimodality radionuclide, fluorescence, and bioluminescence small-animal imaging. Proceedings of the IEEE 93: 771–783
Edinger M, Sweeney TJ, Tucker AA, Olomu AB, Negrin RS, Contag CH (1999) Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia 1: 303–310
Shin JH, Chung JK, Kang JH, Lee YJ, Kim KI, So Y, Jeong JM, Lee DS, Lee MC (2004) Noninvasive imaging for monitoring of viable cancer cells using a dual-imaging reporter gene. J Nucl Med 45: 2109–2115
Sweeney TJ, Mailander V, Tucker AA, Olomu AB, Zhang W, Cao Y, Negrin RS, Contag CH (1999) Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci USA 96: 12044–12049
Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, Ross BD (2000) Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2: 491–495
Adams JY, Johnson M, Sato M, Berger F, Gambhir SS, Carey M, Iruela-Arispe ML, Wu L (2002) Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat Med 8: 891–897
Edinger M, Cao YA, Verneris MR, Bachmann MH, Contag CH, Negrin RS (2003) Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 101: 640–648
Costa GL, Sandora MR, Nakajima A, Nguyen EV, Taylor-Edwards C, Slavin AJ, Contag CH, Fathman CG, Benson JM (2001) Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J Immunol 167: 2379–2387
Lipshutz GS, Gruber CA, Cao Y, Hardy J, Contag CH, Gaensler KM (2001) In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. Mol Ther 3: 284–292
Nakajima A, Seroogy CM, Sandora MR, Tarner IH, Costa GL, Taylor-Edwards C, Bachmann MH, Contag CH, Fathman CG (2001) Antigen-specific T cell-mediated Gene Therapy in collagen-induced arthritis. J Clin Invest 107: 1293–1301
Reynolds PN, Zinn KR, Gavrilyuk VD, Balyasnikova IV, Rogers BE, Buchsbaum DJ, Wang MH, Miletich DJ, Grizzle WE, Douglas JT et al (2000) A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. Mol Ther 2: 562–578
Veselovsky AV, Ivanov YD, Ivanov AS, Archakov AI, Lewi P, Janssen P (2002) Protein-protein interactions: mechanisms and modification by drugs. J Mol Recognit 15: 405–422
Paulmurugan R, Massoud TF, Huang J, Gambhir SS (2004) Molecular imaging of drug-modulated protein-protein interactions in living subjects. Cancer Res 64: 2113–2119
Massoud TF, Paulmurugan R, Gambhir SS (2004) Molecular imaging of homodimeric protein-protein interactions in living subjects. Faseb J 18: 1105–1107
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Birkhäuser Verlag, Basel (Switzerland)
About this chapter
Cite this chapter
Gheysens, O., Gambhir, S.S. (2005). Studying molecular and cellular processes in the intact organism. In: Herrling, P.L., Matter, A., Rudin, M. (eds) Imaging in Drug Discovery and Early Clinical Trials. Progress in Drug Research, vol 62. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7426-8_4
Download citation
DOI: https://doi.org/10.1007/3-7643-7426-8_4
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-7157-9
Online ISBN: 978-3-7643-7426-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)